Selected research
Market Structure
Global Antiretroviral Therapy Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Antiretroviral Therapy market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Antiretroviral Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Antiretroviral Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Antiretroviral Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Antiretroviral Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Antiretroviral Therapy include Janssen Pharmaceuticals, Mylan, Abbvie, ViiV Healthcare, Vertex Pharmaceuticals, Gilead, F. Hoffmann-La Roche, Boehringer Ingelheim and Bionor Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Antiretroviral Therapy market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Antiretroviral Therapy and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Antiretroviral Therapy sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Antiretroviral Therapy market size, projected growth trends, production technologies, key applications, and end-use industries.
Antiretroviral Therapy Segment by Company
Janssen Pharmaceuticals
Mylan
Abbvie
ViiV Healthcare
Vertex Pharmaceuticals
Gilead
F. Hoffmann-La Roche
Boehringer Ingelheim
Bionor Pharma
Antiretroviral Therapy Segment by Type
Integrase Inhibitors
NRTI
NNRTIs
Multiclass Combination Products
Antiretroviral Therapy Segment by Application
Hospital
Clinic
Other
Antiretroviral Therapy Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antiretroviral Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Antiretroviral Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antiretroviral Therapy.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Antiretroviral Therapy market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Antiretroviral Therapy manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Antiretroviral Therapy in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Antiretroviral Therapy in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Integrase Inhibitors
- NRTI
- NNRTIs
- Multiclass Combination Products
Applications
- Hospital
- Clinic
- Other
Companies covered
- Janssen Pharmaceuticals
- Mylan
- Abbvie
- ViiV Healthcare
- Vertex Pharmaceuticals
- Gilead
- F. Hoffmann-La Roche
- Boehringer Ingelheim
- Bionor Pharma
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Antiretroviral Therapy Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Antiretroviral Therapy Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Antiretroviral Therapy Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Antiretroviral Therapy Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Antiretroviral Therapy Market Dynamics
- 2.1 Antiretroviral Therapy Industry Trends
- 2.2 Antiretroviral Therapy Industry Drivers
- 2.3 Antiretroviral Therapy Industry Opportunities and Challenges
- 2.4 Antiretroviral Therapy Industry Restraints
3 Antiretroviral Therapy Market by Manufacturers
- 3.1 Global Antiretroviral Therapy Revenue by Manufacturers (2021-2026)
- 3.2 Global Antiretroviral Therapy Sales by Manufacturers (2021-2026)
- 3.3 Global Antiretroviral Therapy Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Antiretroviral Therapy Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Antiretroviral Therapy Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Antiretroviral Therapy Manufacturers, Product Type & Application
- 3.7 Global Antiretroviral Therapy Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Antiretroviral Therapy Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Antiretroviral Therapy Players Market Share by Revenue in 2025
- 3.8.3 2025 Antiretroviral Therapy Tier 1, Tier 2, and Tier 3
4 Antiretroviral Therapy Market by Type
- 4.1 Antiretroviral Therapy Type Introduction
- 4.1.1 Integrase Inhibitors
- 4.1.2 NRTI
- 4.1.3 NNRTIs
- 4.1.4 Multiclass Combination Products
- 4.2 Global Antiretroviral Therapy Sales by Type
- 4.2.1 Global Antiretroviral Therapy Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Antiretroviral Therapy Sales by Type (2021-2032)
- 4.2.3 Global Antiretroviral Therapy Sales Market Share by Type (2021-2032)
- 4.3 Global Antiretroviral Therapy Revenue by Type
- 4.3.1 Global Antiretroviral Therapy Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Antiretroviral Therapy Revenue by Type (2021-2032)
- 4.3.3 Global Antiretroviral Therapy Revenue Market Share by Type (2021-2032)
5 Antiretroviral Therapy Market by Application
- 5.1 Antiretroviral Therapy Application Introduction
- 5.1.1 Hospital
- 5.1.2 Clinic
- 5.1.3 Other
- 5.2 Global Antiretroviral Therapy Sales by Application
- 5.2.1 Global Antiretroviral Therapy Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Antiretroviral Therapy Sales by Application (2021-2032)
- 5.2.3 Global Antiretroviral Therapy Sales Market Share by Application (2021-2032)
- 5.3 Global Antiretroviral Therapy Revenue by Application
- 5.3.1 Global Antiretroviral Therapy Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Antiretroviral Therapy Revenue by Application (2021-2032)
- 5.3.3 Global Antiretroviral Therapy Revenue Market Share by Application (2021-2032)
6 Global Antiretroviral Therapy Sales by Region
- 6.1 Global Antiretroviral Therapy Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Antiretroviral Therapy Sales by Region (2021-2032)
- 6.2.1 Global Antiretroviral Therapy Sales by Region (2021-2026)
- 6.2.2 Global Antiretroviral Therapy Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Antiretroviral Therapy Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Antiretroviral Therapy Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Antiretroviral Therapy Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Antiretroviral Therapy Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Antiretroviral Therapy Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Antiretroviral Therapy Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Antiretroviral Therapy Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Antiretroviral Therapy Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Antiretroviral Therapy Revenue by Region
- 7.1 Global Antiretroviral Therapy Revenue by Region
- 7.1.1 Global Antiretroviral Therapy Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Antiretroviral Therapy Revenue by Region (2021-2026)
- 7.1.3 Global Antiretroviral Therapy Revenue by Region (2027-2032)
- 7.1.4 Global Antiretroviral Therapy Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Antiretroviral Therapy Revenue (2021-2032)
- 7.2.2 North America Antiretroviral Therapy Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Antiretroviral Therapy Revenue (2021-2032)
- 7.3.2 Europe Antiretroviral Therapy Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Antiretroviral Therapy Revenue (2021-2032)
- 7.4.2 Asia-Pacific Antiretroviral Therapy Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Antiretroviral Therapy Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Antiretroviral Therapy Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Janssen Pharmaceuticals
- 8.1.1 Janssen Pharmaceuticals Company Information
- 8.1.2 Janssen Pharmaceuticals Business Overview
- 8.1.3 Janssen Pharmaceuticals Antiretroviral Therapy Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Janssen Pharmaceuticals Antiretroviral Therapy Product Portfolio
- 8.1.5 Janssen Pharmaceuticals Recent Developments
- 8.2 Mylan
- 8.2.1 Mylan Company Information
- 8.2.2 Mylan Business Overview
- 8.2.3 Mylan Antiretroviral Therapy Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Mylan Antiretroviral Therapy Product Portfolio
- 8.2.5 Mylan Recent Developments
- 8.3 Abbvie
- 8.3.1 Abbvie Company Information
- 8.3.2 Abbvie Business Overview
- 8.3.3 Abbvie Antiretroviral Therapy Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Abbvie Antiretroviral Therapy Product Portfolio
- 8.3.5 Abbvie Recent Developments
- 8.4 ViiV Healthcare
- 8.4.1 ViiV Healthcare Company Information
- 8.4.2 ViiV Healthcare Business Overview
- 8.4.3 ViiV Healthcare Antiretroviral Therapy Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 ViiV Healthcare Antiretroviral Therapy Product Portfolio
- 8.4.5 ViiV Healthcare Recent Developments
- 8.5 Vertex Pharmaceuticals
- 8.5.1 Vertex Pharmaceuticals Company Information
- 8.5.2 Vertex Pharmaceuticals Business Overview
- 8.5.3 Vertex Pharmaceuticals Antiretroviral Therapy Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Vertex Pharmaceuticals Antiretroviral Therapy Product Portfolio
- 8.5.5 Vertex Pharmaceuticals Recent Developments
- 8.6 Gilead
- 8.6.1 Gilead Company Information
- 8.6.2 Gilead Business Overview
- 8.6.3 Gilead Antiretroviral Therapy Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Gilead Antiretroviral Therapy Product Portfolio
- 8.6.5 Gilead Recent Developments
- 8.7 F. Hoffmann-La Roche
- 8.7.1 F. Hoffmann-La Roche Company Information
- 8.7.2 F. Hoffmann-La Roche Business Overview
- 8.7.3 F. Hoffmann-La Roche Antiretroviral Therapy Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 F. Hoffmann-La Roche Antiretroviral Therapy Product Portfolio
- 8.7.5 F. Hoffmann-La Roche Recent Developments
- 8.8 Boehringer Ingelheim
- 8.8.1 Boehringer Ingelheim Company Information
- 8.8.2 Boehringer Ingelheim Business Overview
- 8.8.3 Boehringer Ingelheim Antiretroviral Therapy Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Boehringer Ingelheim Antiretroviral Therapy Product Portfolio
- 8.8.5 Boehringer Ingelheim Recent Developments
- 8.9 Bionor Pharma
- 8.9.1 Bionor Pharma Company Information
- 8.9.2 Bionor Pharma Business Overview
- 8.9.3 Bionor Pharma Antiretroviral Therapy Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Bionor Pharma Antiretroviral Therapy Product Portfolio
- 8.9.5 Bionor Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Antiretroviral Therapy Value Chain Analysis
- 9.1.1 Antiretroviral Therapy Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Antiretroviral Therapy Production Mode & Process
- 9.2 Antiretroviral Therapy Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Antiretroviral Therapy Distributors
- 9.2.3 Antiretroviral Therapy Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst